Wordt geladen...
Increased systemic exposures of artemether and dihydroartemisinin in infants under 5 kg with uncomplicated Plasmodium falciparum malaria treated with artemether-lumefantrine (Coartem®)
BACKGROUND: Artemether-lumefantrine (AL) dispersible formulation was developed for the treatment of uncomplicated Plasmodium falciparum malaria in infants and children weighing 5 to <35 kg. However, there are no clinical studies with artemisinin-based combination therapy in infants <5 kg. METH...
Bewaard in:
| Gepubliceerd in: | Malar J |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
BioMed Central
2015
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4407414/ https://ncbi.nlm.nih.gov/pubmed/25886021 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12936-015-0682-7 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|